{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:50:20Z","timestamp":1782179420833,"version":"3.54.5"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1038\/ncpneuro0395","type":"journal-article","created":{"date-parts":[[2007,1,5]],"date-time":"2007-01-05T11:21:17Z","timestamp":1167996077000},"page":"24-35","source":"Crossref","is-referenced-by-count":88,"title":["Primary CNS lymphoma"],"prefix":"10.1038","volume":"3","author":[{"given":"Fred H","family":"Hochberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim M","family":"Baehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephraim P","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpneuro0395_CR1","unstructured":"Central Brain Tumor Registry of the United States (2005) Statistical Report: Primary Brain Tumors in the United States 1998\u20132002 (Years Data Collected). [ http:\/\/www.cbtrus.org\/reports\/\/2005-2006\/2006report.pdf ]"},{"key":"BFncpneuro0395_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","volume":"56","author":"A Jemal","year":"2006","unstructured":"Jemal A et al. (2006) Cancer statistics, 2006. CA Cancer J Clin 56: 106\u2013130","journal-title":"CA Cancer J Clin"},{"key":"BFncpneuro0395_CR3","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/cncr.10851","volume":"95","author":"JE Olson","year":"2002","unstructured":"Olson JE et al. (2002) The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 95: 1504\u20131510","journal-title":"Cancer"},{"key":"BFncpneuro0395_CR4","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.2000.18.19.3325","volume":"18","author":"A Cingolani","year":"2000","unstructured":"Cingolani A et al. (2000) Epstein\u2013Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas. J Clin Oncol 18: 3325\u20133330","journal-title":"J Clin Oncol"},{"key":"BFncpneuro0395_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1212\/WNL.56.2.257","volume":"56","author":"N Sacktor","year":"2001","unstructured":"Sacktor N et al. (2001) HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990\u20131998. Neurology 56: 257\u2013260","journal-title":"Neurology"},{"key":"BFncpneuro0395_CR6","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/jnci\/djj302","volume":"98","author":"M Bower","year":"2006","unstructured":"Bower M et al. (2006) Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma. J Natl Cancer Inst 98: 1088\u20131091","journal-title":"J Natl Cancer Inst"},{"key":"BFncpneuro0395_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00043426-198722000-00017","volume":"9","author":"AH Filipovich","year":"1987","unstructured":"Filipovich AH et al. (1987) The Immunodeficiency Cancer Registry: a research resource. Am J Pediatr Hematol Oncol 9: 183\u2013184","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"BFncpneuro0395_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1309\/N82CTQ1J0XEVEFQB","volume":"121","author":"AA Castellano-Sanchez","year":"2004","unstructured":"Castellano-Sanchez AA et al. (2004) Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol 121: 246\u2013253","journal-title":"Am J Clin Pathol"},{"key":"BFncpneuro0395_CR9","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1200\/JCO.1998.16.6.2052","volume":"16","author":"V Leblond","year":"1998","unstructured":"Leblond V et al. (1998) Posttransplant lymphoproliferative disorders not associated with Epstein\u2013Barr virus: a distinct entity? J Clin Oncol 16: 2052\u20132059","journal-title":"J Clin Oncol"},{"key":"BFncpneuro0395_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/jnnp.60.1.102","volume":"60","author":"L Alderson","year":"1996","unstructured":"Alderson L et al. (1996) Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry 60: 102\u2013105","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpneuro0395_CR11","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/blood.V95.6.1900","volume":"95","author":"P Drillenburg","year":"2000","unstructured":"Drillenburg P and Pals ST (2000) Cell adhesion receptors in lymphoma dissemination. Blood 95: 1900\u20131910","journal-title":"Blood"},{"key":"BFncpneuro0395_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","volume":"76","author":"TA Springer","year":"1994","unstructured":"Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301\u2013314","journal-title":"Cell"},{"key":"BFncpneuro0395_CR13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1182\/blood-2002-05-1576","volume":"101","author":"JR Smith","year":"2003","unstructured":"Smith JR et al. (2003) Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood 101: 815\u2013821","journal-title":"Blood"},{"key":"BFncpneuro0395_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00172658","volume":"12","author":"R Bashir","year":"1992","unstructured":"Bashir R et al. (1992) Expression of LFA-1\/ICAM-1 in CNS lymphomas: possible mechanism for lymphoma homing into the brain. J Neurooncol 12: 103\u2013110","journal-title":"J Neurooncol"},{"key":"BFncpneuro0395_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/00005072-199705000-00012","volume":"56","author":"R Aho","year":"1997","unstructured":"Aho R et al. (1997) Binding of malignant lymphoid cells to the white matter of the human central nervous system: role of different CD44 isoforms, beta 1, beta 2 and beta 7 integrins, and L-selectin. J Neuropathol Exp Neurol 56: 557\u2013568","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFncpneuro0395_CR16","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1200\/JCO.2006.06.7165","volume":"24","author":"K Jahnke","year":"2006","unstructured":"Jahnke K et al. (2006) Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes. J Clin Oncol 24: 4754\u20134757","journal-title":"J Clin Oncol"},{"key":"BFncpneuro0395_CR17","first-page":"1011","volume":"92","author":"LM Larocca","year":"1998","unstructured":"Larocca LM et al. (1998) The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 92: 1011\u20131019","journal-title":"Blood"},{"key":"BFncpneuro0395_CR18","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0002-9440(10)65526-5","volume":"155","author":"M Montesinos-Rongen","year":"1999","unstructured":"Montesinos-Rongen M et al. (1999) Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol 155: 2077\u20132086","journal-title":"Am J Pathol"},{"key":"BFncpneuro0395_CR19","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/blood.V94.5.1738","volume":"94","author":"AR Thompsett","year":"1999","unstructured":"Thompsett AR et al. (1999) VH gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. Blood 94: 1738\u20131746","journal-title":"Blood"},{"key":"BFncpneuro0395_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503\u2013511","journal-title":"Nature"},{"key":"BFncpneuro0395_CR21","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald A et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937\u20131947","journal-title":"N Engl J Med"},{"key":"BFncpneuro0395_CR22","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2005-03-0897","volume":"107","author":"JL Rubenstein","year":"2006","unstructured":"Rubenstein JL et al. (2006) Gene expression and angiotropism in primary CNS lymphoma. Blood 107: 3716\u20133723","journal-title":"Blood"},{"key":"BFncpneuro0395_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/35085588","volume":"412","author":"L Pasqualucci","year":"2001","unstructured":"Pasqualucci L et al. (2001) Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412: 341\u2013346","journal-title":"Nature"},{"key":"BFncpneuro0395_CR24","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1182\/blood-2003-05-1465","volume":"103","author":"M Montesinos-Rongen","year":"2004","unstructured":"Montesinos-Rongen M et al. (2004) Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood 103: 1869\u20131875","journal-title":"Blood"},{"issue":"Suppl 1","key":"BFncpneuro0395_CR25","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/S0092-8674(02)00706-7","volume":"109","author":"FN Papavasiliou","year":"2002","unstructured":"Papavasiliou FN and Schatz DG (2002) Somatic hypermutation of immunoglobulin genes: merging mechanisms for genetic diversity. Cell 109 (Suppl 1): S35\u2013S44","journal-title":"Cell"},{"key":"BFncpneuro0395_CR26","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/01.jnen.0000229988.48042.ae","volume":"65","author":"H Schwindt","year":"2006","unstructured":"Schwindt H et al. (2006) Chromosomal translocations fusing the BCL6 gene to different partner loci are recurrent in primary central nervous system lymphoma and may be associated with aberrant somatic hypermutation or defective class switch recombination. J Neuropathol Exp Neurol 65: 776\u2013782","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFncpneuro0395_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1750-3639.2000.tb00244.x","volume":"10","author":"T Weber","year":"2000","unstructured":"Weber T et al. (2000) Characteristic chromosomal imbalances in primary central nervous system lymphomas of the diffuse large B-cell type. Brain Pathol 10: 73\u201384","journal-title":"Brain Pathol"},{"key":"BFncpneuro0395_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/gcc.10093","volume":"35","author":"ES Jordanova","year":"2002","unstructured":"Jordanova ES et al. (2002) Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system. Genes Chromosomes Cancer 35: 38\u201348","journal-title":"Genes Chromosomes Cancer"},{"key":"BFncpneuro0395_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1056\/NEJM198309293091301","volume":"309","author":"FH Hochberg","year":"1983","unstructured":"Hochberg FH et al. (1983) Central-nervous-system lymphoma related to Epstein\u2013Barr virus. N Engl J Med 309: 745\u2013748","journal-title":"N Engl J Med"},{"key":"BFncpneuro0395_CR30","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1126\/science.2986287","volume":"228","author":"ML Cleary","year":"1985","unstructured":"Cleary ML et al. (1985) Individual tumors of multifocal EB virus-induced malignant lymphomas in tamarins arise from different B-cell clones. Science 228: 722\u2013724","journal-title":"Science"},{"key":"BFncpneuro0395_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9440(10)64697-4","volume":"156","author":"RF Ambinder","year":"2000","unstructured":"Ambinder RF (2000) Gammaherpesviruses and 'hit-and-run' oncogenesis. Am J Pathol 156: 1\u20133","journal-title":"Am J Pathol"},{"key":"BFncpneuro0395_CR32","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.molimm.2006.03.018","volume":"44","author":"M Epeldegui","year":"2007","unstructured":"Epeldegui M et al. (2007) Infection of human B cells with Epstein\u2013Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol Immunol 44: 934\u2013942","journal-title":"Mol Immunol"},{"key":"BFncpneuro0395_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/jnci\/djj004","volume":"98","author":"KE Smedby","year":"2006","unstructured":"Smedby KE et al. (2006) Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98: 51\u201360","journal-title":"J Natl Cancer Inst"},{"key":"BFncpneuro0395_CR34","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","volume":"165","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E et al. (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165: 2337\u20132344","journal-title":"Arch Intern Med"},{"key":"BFncpneuro0395_CR35","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1002\/1097-0142(19930515)71:10<3156::AID-CNCR2820711043>3.0.CO;2-O","volume":"71","author":"J Glass","year":"1993","unstructured":"Glass J et al. (1993) Intravascular lymphomatosis: a systemic disease with neurologic manifestations. Cancer 71: 3156\u20133164","journal-title":"Cancer"},{"key":"BFncpneuro0395_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1215\/15228517-5-2-104","volume":"5","author":"JM Baehring","year":"2003","unstructured":"Baehring JM et al. (2003) Neurolymphomatosis. Neuro-oncol 5: 104\u2013115","journal-title":"Neuro-oncol"},{"key":"BFncpneuro0395_CR37","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/S0161-6420(99)90341-X","volume":"106","author":"EK Akpek","year":"1999","unstructured":"Akpek EK et al. (1999) Intraocular\u2013central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 106: 1805\u20131810","journal-title":"Ophthalmology"},{"key":"BFncpneuro0395_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1212\/WNL.57.3.393","volume":"57","author":"U Buhring","year":"2001","unstructured":"Buhring U et al. (2001) MRI features of primary central nervous system lymphomas at presentation. Neurology 57: 393\u2013396","journal-title":"Neurology"},{"key":"BFncpneuro0395_CR39","doi-asserted-by":"publisher","first-page":"5524","DOI":"10.1073\/pnas.0501532102","volume":"102","author":"BA Moffat","year":"2005","unstructured":"Moffat BA et al. (2005) Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 102: 5524\u20135529","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneuro0395_CR40","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR et al. (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277\u20131280","journal-title":"J Clin Oncol"},{"key":"BFncpneuro0395_CR41","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/ana.20804","volume":"59","author":"K Jahnke","year":"2006","unstructured":"Jahnke K et al. (2006) International study on low-grade primary central nervous system lymphoma. Ann Neurol 59: 755\u2013762","journal-title":"Ann Neurol"},{"key":"BFncpneuro0395_CR42","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1212\/WNL.57.4.716","volume":"57","author":"JM Gijtenbeek","year":"2001","unstructured":"Gijtenbeek JM et al. (2001) Primary central nervous system T-cell lymphoma. Neurology 57: 716\u2013718","journal-title":"Neurology"},{"key":"BFncpneuro0395_CR43","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1212\/WNL.58.3.390","volume":"58","author":"B Gleissner","year":"2002","unstructured":"Gleissner B et al. (2002) CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes. Neurology 58: 390\u2013396","journal-title":"Neurology"},{"key":"BFncpneuro0395_CR44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/cncr.21191","volume":"104","author":"JM Baehring","year":"2005","unstructured":"Baehring JM et al. (2005) Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma. Cancer 104: 591\u2013597","journal-title":"Cancer"},{"key":"BFncpneuro0395_CR45","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jns.2006.05.044","volume":"247","author":"JM Baehring","year":"2006","unstructured":"Baehring JM et al. (2006) Immunoglobulin gene rearrangement analysis in cerebrospinal fluid of patients with lymphoproliferative processes. J Neurol Sci 247: 208\u2013216","journal-title":"J Neurol Sci"},{"key":"BFncpneuro0395_CR46","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1086\/420934","volume":"38","author":"LC Ivers","year":"2004","unstructured":"Ivers LC et al. (2004) Predictive value of polymerase chain reaction of cerebrospinal fluid for detection of Epstein\u2013Barr virus to establish the diagnosis of HIV-related primary central nervous system lymphoma. Clin Infect Dis 38: 1629\u20131632","journal-title":"Clin Infect Dis"},{"key":"BFncpneuro0395_CR47","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/jnci\/90.5.364","volume":"90","author":"A Cingolani","year":"1998","unstructured":"Cingolani A et al. (1998) Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J Natl Cancer Inst 90: 364\u2013369","journal-title":"J Natl Cancer Inst"},{"key":"BFncpneuro0395_CR48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3171\/jns.2000.92.2.0261","volume":"92","author":"B Bataille","year":"2000","unstructured":"Bataille B et al. (2000) Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 92: 261\u2013266","journal-title":"J Neurosurg"},{"key":"BFncpneuro0395_CR49","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1212\/WNL.46.6.1757","volume":"46","author":"L Cher","year":"1996","unstructured":"Cher L et al. (1996) Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results. Neurology 46: 1757\u20131759","journal-title":"Neurology"},{"key":"BFncpneuro0395_CR50","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1200\/JCO.2003.03.036","volume":"21","author":"T Batchelor","year":"2003","unstructured":"Batchelor T et al. (2003) Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol 21: 1044\u20131049","journal-title":"J Clin Oncol"},{"key":"BFncpneuro0395_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/sj.bjc.6601472","volume":"90","author":"AJ Ferreri","year":"2004","unstructured":"Ferreri AJ et al. (2004) Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas. Br J Cancer 90: 353\u2013358","journal-title":"Br J Cancer"},{"key":"BFncpneuro0395_CR52","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y","volume":"88","author":"ND Doolittle","year":"2000","unstructured":"Doolittle ND et al. (2000) Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood\u2013brain barrier for the treatment of patients with malignant brain tumors. Cancer 88: 637\u2013647","journal-title":"Cancer"},{"key":"BFncpneuro0395_CR53","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1200\/JCO.2002.11.013","volume":"20","author":"LM DeAngelis","year":"2002","unstructured":"DeAngelis LM et al. (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 20: 4643\u20134648","journal-title":"J Clin Oncol"},{"key":"BFncpneuro0395_CR54","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1200\/JCO.2003.03.108","volume":"21","author":"PM Poortmans","year":"2003","unstructured":"Poortmans PM et al. (2003) High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. J Clin Oncol 21: 4483\u20134488","journal-title":"J Clin Oncol"},{"key":"BFncpneuro0395_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0360-3016(92)90538-S","volume":"23","author":"DF Nelson","year":"1992","unstructured":"Nelson DF et al. (1992) Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 23: 9\u201317","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFncpneuro0395_CR56","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/A:1016077907952","volume":"58","author":"RB Khan","year":"2002","unstructured":"Khan RB et al. (2002) Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma? J Neurooncol 58: 175\u2013178","journal-title":"J Neurooncol"},{"key":"BFncpneuro0395_CR57","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1158\/1078-0432.CCR-04-0159","volume":"10","author":"SR Plotkin","year":"2004","unstructured":"Plotkin SR et al. (2004) Treatment of relapsed central nervous system lymphoma with high-dose methotrexate. Clin Cancer Res 10: 5643\u20135646","journal-title":"Clin Cancer Res"},{"key":"BFncpneuro0395_CR58","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1212\/01.WNL.0000137050.43114.42","volume":"63","author":"RH Enting","year":"2004","unstructured":"Enting RH et al. (2004) Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology 63: 901\u2013903","journal-title":"Neurology"},{"key":"BFncpneuro0395_CR59","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1200\/JCO.2005.01.161","volume":"23","author":"PL Nguyen","year":"2005","unstructured":"Nguyen PL et al. (2005) Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. J Clin Oncol 23: 1507\u20131513","journal-title":"J Clin Oncol"},{"key":"BFncpneuro0395_CR60","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1200\/JCO.2001.19.3.742","volume":"19","author":"C Soussain","year":"2001","unstructured":"Soussain C et al. (2001) Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 19: 742\u2013749","journal-title":"J Clin Oncol"},{"key":"BFncpneuro0395_CR61","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1200\/JCO.2003.05.024","volume":"21","author":"LE Abrey","year":"2003","unstructured":"Abrey LE et al. (2003) Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis. J Clin Oncol 21: 4151\u20134156","journal-title":"J Clin Oncol"},{"key":"BFncpneuro0395_CR62","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1212\/WNL.44.8.1473","volume":"44","author":"PA Forsyth","year":"1994","unstructured":"Forsyth PA et al. (1994) Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 44: 1473\u20131479","journal-title":"Neurology"},{"key":"BFncpneuro0395_CR63","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1002\/cncr.20300","volume":"100","author":"ME Newell","year":"2004","unstructured":"Newell ME et al. (2004) Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer 100: 2627\u20132636","journal-title":"Cancer"},{"key":"BFncpneuro0395_CR64","first-page":"965","volume":"63","author":"S Roychowdhury","year":"2003","unstructured":"Roychowdhury S et al. (2003) Experimental treatment of Epstein\u2013Barr virus-associated primary central nervous system lymphoma. Cancer Res 63: 965\u2013971","journal-title":"Cancer Res"},{"key":"BFncpneuro0395_CR65","first-page":"711","volume":"9","author":"TT Batchelor","year":"2003","unstructured":"Batchelor TT et al. (2003) High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 9: 711\u2013715","journal-title":"Clin Cancer Res"},{"key":"BFncpneuro0395_CR66","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S0161-6420(02)01125-9","volume":"109","author":"JR Smith","year":"2002","unstructured":"Smith JR et al. (2002) Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 109: 1709\u20131716","journal-title":"Ophthalmology"},{"key":"BFncpneuro0395_CR67","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/archneur.60.4.563","volume":"60","author":"K Fliessbach","year":"2003","unstructured":"Fliessbach K et al. (2003) Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma. Arch Neurol 60: 563\u2013568","journal-title":"Arch Neurol"},{"key":"BFncpneuro0395_CR68","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1001\/archneur.62.10.1595","volume":"62","author":"AM Omuro","year":"2005","unstructured":"Omuro AM et al. (2005) Delayed neurotoxicity in primary central nervous system lymphoma. Arch Neurol 62: 1595\u20131600","journal-title":"Arch Neurol"},{"key":"BFncpneuro0395_CR69","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1212\/01.WNL.0000109673.75316.D8","volume":"62","author":"DD Correa","year":"2004","unstructured":"Correa DD et al. (2004) Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 62: 548\u2013555","journal-title":"Neurology"},{"key":"BFncpneuro0395_CR70","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1212\/WNL.62.4.544","volume":"62","author":"H Harder","year":"2004","unstructured":"Harder H et al. (2004) Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology 62: 544\u2013547","journal-title":"Neurology"},{"key":"BFncpneuro0395_CR71","unstructured":"Neuro-oncological Working Group of the German Cancer Society [German] [ http:\/\/www.neuroonkologie.de ]"},{"key":"BFncpneuro0395_CR72","unstructured":"Phase IV study on the role of whole-brain radiation in the primary therapy of primary CNS lymphoma with high-dose methotrexate [German] [ http:\/\/www.charite.de\/haema-cbf\/pcnsl.htm ]"},{"issue":"Suppl","key":"BFncpneuro0395_CR73","doi-asserted-by":"crossref","first-page":"A7595","DOI":"10.1200\/jco.2006.24.18_suppl.7595","volume":"24","author":"S Issa","year":"2006","unstructured":"Issa S et al. (2006) Treatment of primary CNS lymphoma with induction high-dose methotrexate, temozolomide, rituximab followed by consolidation cytarabine\/etoposide: a pilot study with biomarker analysis [abstract]. J Clin Oncol 24 (Suppl): A7595","journal-title":"J Clin Oncol"},{"key":"BFncpneuro0395_CR74","unstructured":"Radiation Therapy Oncology Group [ http:\/\/www.rtog.org ]"},{"key":"BFncpneuro0395_CR75","unstructured":"ClinicalTrials.gov [ http:\/\/clinicaltrials.gov ]"},{"key":"BFncpneuro0395_CR76","unstructured":"Memorial Sloan\u2013Kettering Cancer Center, New York [ http:\/\/www.mskcc.org ]"},{"key":"BFncpneuro0395_CR77","unstructured":"Oregon Health & Science University [ http:\/\/www.ohsu.edu ]"},{"key":"BFncpneuro0395_CR78","unstructured":"Eastern Cooperative Oncology Group [ http:\/\/www.ecog.org ]"},{"key":"BFncpneuro0395_CR79","unstructured":"International Extranodal Lymphoma Study Group [ http:\/\/www.ielsg.org ]"},{"key":"BFncpneuro0395_CR80","unstructured":"National Cancer Institute Clinical Trials [ http:\/\/www.cancer.gov\/clinicaltrials ]"},{"key":"BFncpneuro0395_CR81","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/cncr.21481","volume":"104","author":"KS Panageas","year":"2005","unstructured":"Panageas KS et al. (2005) Trends in survival from primary central nervous system lymphoma, 1975\u20131999: a population-based analysis. Cancer 104: 2466\u20132472","journal-title":"Cancer"},{"key":"BFncpneuro0395_CR82","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1200\/JCO.2000.18.17.3144","volume":"18","author":"LE Abrey","year":"2000","unstructured":"Abrey LE et al. (2000) Treatment for primary CNS lymphoma: the next step. J Clin Oncol 18: 3144\u20133150","journal-title":"J Clin Oncol"},{"key":"BFncpneuro0395_CR83","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/neurosurgery\/46.1.51","volume":"46","author":"LD McAllister","year":"2000","unstructured":"McAllister LD et al. (2000) Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. Neurosurgery 46: 51\u201360","journal-title":"Neurosurgery"},{"key":"BFncpneuro0395_CR84","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1200\/JCO.2003.04.056","volume":"21","author":"H Pels","year":"2003","unstructured":"Pels H et al. (2003) Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 21: 4489\u20134495","journal-title":"J Clin Oncol"},{"key":"BFncpneuro0395_CR85","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1200\/JCO.2005.13.524","volume":"23","author":"LE Abrey","year":"2005","unstructured":"Abrey LE et al. (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23: 5034\u20135043","journal-title":"J Clin Oncol"}],"container-title":["Nature Clinical Practice Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0395","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:28:40Z","timestamp":1684441720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["BFncpneuro0395"],"URL":"https:\/\/doi.org\/10.1038\/ncpneuro0395","relation":{},"ISSN":["1745-834X","1745-8358"],"issn-type":[{"value":"1745-834X","type":"print"},{"value":"1745-8358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}